A post on the Global Health Technologies Coalition’s (GHTC) “Breakthroughs” blog describes an event to launch a recent report from GHTC and Policy Cures on “data on U.S. investments over the past 10 years in global health research and development (R&D).” The event, co-hosted by Research!America, featured comments from panelists Javier Guzman, director of research at Policy Cures; Lee Hall, chief of the Parasitology and International Programs Branch at the National Institute of Allergy and Infectious Diseases (NIAID); Heather Ignatius, senior manager for policy at the Global Alliance for TB Drug Development; and Eric Easom, program leader for neglected diseases at Anacor Pharmaceuticals, according to the blog (Lufkin, 5/1).